Skip to content

An Evaluation of the Families Addressing Cancer Together (FACT) Intervention

A Pilot Study Evaluating the Feasibility, Acceptability, and Preliminary Evidence of Efficacy of the Families Addressing Cancer Together (FACT) Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04342871
Acronym
FACT
Enrollment
53
Registered
2020-04-13
Start date
2020-10-05
Completion date
2021-07-27
Last updated
2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Communication, Neoplasms, Parent-Child Relations, Parenting, Parents

Brief summary

This is a pilot feasibility and acceptability study to inform the development and testing of a novel communication intervention to support parents in their communication with children about cancer. The research questions to be answered by this study are whether the intervention being tested can be feasible and acceptable, and provide preliminary estimates of improvement in parental psychological distress.

Detailed description

This is a single-arm, single center pilot study using a pretest-posttest design to evaluate the feasibility and acceptability of a psychosocial intervention, Families Addressing Cancer Together (FACT). The purpose of the intervention is to decrease parental anxiety by facilitating parental communication about cancer with their children. The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible, acceptable, and reduce parental psychological distress. Findings from this study will inform a future grant application to further test this intervention in a randomized controlled trial.

Interventions

BEHAVIORALFACT

Customized communication guidance to help parents with cancer talk about their cancer with their children.

Sponsors

UNC Lineberger Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Because this is a pilot study, all participants will receive the same intervention and no blinding will take place

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent reviewed and signed; * Age equal to or above 18 years; * Ability to understand and comply with study procedures; * Be a parent, primary caregiver, or guardian of at least one child between the ages of 3-19 years old with whom the subject has regular contact. The child must have cognitive ability to understand verbal communication; * Have a new or recurrent diagnosis of invasive solid tumor malignancy within the past 6 months or have a solid tumor cancer diagnosis with disease that is either stage IV or equivalent; * Have a cancer diagnosis that is likely to require systemic anti-neoplastic therapy, non-office based surgical intervention, radiation therapy, or palliative care/hospice within the next three months.

Exclusion criteria

* Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes.

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form- Overall Satisfaction14 daysAcceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.
Acceptability of the Intervention Assessed Via Semi-structured Interviews14 daysParticipants were interviewed about their experiences with the study intervention using semi-structured interviews. Parents' comments on the intervention helped them feel more comfortable and prepared to talk with their children about their illness were graded as participants overall intervention satisfaction.
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form-FACT Was Useful14 daysAcceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form Content Was Important14 daysAcceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.
Acceptability of the Intervention Measured by the Study Visit Satisfaction Form FACT Was Helpful14 daysAcceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.

Secondary

MeasureTime frameDescription
Feasibility of RecruitmentBaselineNumber of patients who enroll in the study
Communication Self-efficacy Measured by the Adapted Communication Self-Efficacy ScaleBaseline, 14 days, 84 daysAssess the change in patient's communication self-efficacy. The adapted Communication Self-Efficacy scale is a 9-item Visual Analogue Scale assessing parent's confidence in their ability to tell their child about parental medical illness. The score range is 0 to 100 with higher scores indicating higher confidence.
Feasibility of ScreeningBaselineThe number of subjects who were screened, recruited, and retained in the study were reported.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from October 2020 to April 2021 in one center in North Carolina. Although 53 participants consented, 5 subjects did not complete the baseline assessment, and 2 subjects' clinical conditions did not allow them to complete the study requirements. Forty -six participants received the baseline intervention, 35 out of 46 participants completed the 2-week intervention, and 29 out of 35 participants completed the 12-week intervention.

Pre-assignment details

All participants were assigned to receive the intervention after completing baseline assessments.

Participants by arm

ArmCount
FACT
Patients will receive access to intervention materials. FACT: Customized communication guidance to help parents with cancer talk about their cancer with their children.
53
Total53

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyClinical deterioration/illness progression2
Overall StudyDeath4
Overall StudyDid not complete baseline assessments5
Overall StudyLost to Follow-up13

Baseline characteristics

CharacteristicFACT
Age, Continuous45.87 years
STANDARD_DEVIATION 7.14
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
51 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
39 Participants
Sex: Female, Male
Female
35 Participants
Sex: Female, Male
Male
18 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
4 / 53
other
Total, other adverse events
0 / 53
serious
Total, serious adverse events
0 / 53

Outcome results

Primary

Acceptability of the Intervention Assessed Via Semi-structured Interviews

Participants were interviewed about their experiences with the study intervention using semi-structured interviews. Parents' comments on the intervention helped them feel more comfortable and prepared to talk with their children about their illness were graded as participants overall intervention satisfaction.

Time frame: 14 days

Population: Individuals who received intervention materials and participated in semi-structured feedback interview

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
FACT Was HelpfulAcceptability of the Intervention Assessed Via Semi-structured InterviewsIntervention was satisfactory10 Participants
FACT Was HelpfulAcceptability of the Intervention Assessed Via Semi-structured InterviewsIntervention was not satisfactory0 Participants
Primary

Acceptability of the Intervention Measured by the Study Visit Satisfaction Form Content Was Important

Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.

Time frame: 14 days

Population: Participants who completed 2-week satisfaction assessment, reporting acceptability (Somewhat or very helpful) on 4-point scale

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form Content Was ImportantYes27 Participants
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form Content Was ImportantNo2 Participants
Primary

Acceptability of the Intervention Measured by the Study Visit Satisfaction Form FACT Was Helpful

Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.

Time frame: 14 days

Population: Participants who completed 2-week satisfaction assessment, reporting acceptability (Somewhat or very helpful) on 4-point scale

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form FACT Was HelpfulYes26 Participants
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form FACT Was HelpfulNo3 Participants
Primary

Acceptability of the Intervention Measured by the Study Visit Satisfaction Form-FACT Was Useful

Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.

Time frame: 14 days

Population: Participants who completed 2-week satisfaction assessment, reporting acceptability (Somewhat or very helpful) on 4-point scale

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form-FACT Was UsefulNo3 Participants
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form-FACT Was UsefulYes26 Participants
Primary

Acceptability of the Intervention Measured by the Study Visit Satisfaction Form- Overall Satisfaction

Acceptability of the intervention will be assessed through participants' satisfaction ratings used a study-specific satisfaction scale, Families Addressing Cancer Together (FACT) satisfaction scale. Four-items (0=not at all, 3=very), higher scores indicate more satisfaction.

Time frame: 14 days

Population: Participants who completed 2-week satisfaction assessment, reporting acceptability (Somewhat or very helpful) on 4-point scale

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form- Overall SatisfactionYes27 Participants
FACT Was HelpfulAcceptability of the Intervention Measured by the Study Visit Satisfaction Form- Overall SatisfactionNo2 Participants
Secondary

Communication Self-efficacy Measured by the Adapted Communication Self-Efficacy Scale

Assess the change in patient's communication self-efficacy. The adapted Communication Self-Efficacy scale is a 9-item Visual Analogue Scale assessing parent's confidence in their ability to tell their child about parental medical illness. The score range is 0 to 100 with higher scores indicating higher confidence.

Time frame: Baseline, 14 days, 84 days

Population: Participants who completed the Communication self-efficacy scale at baseline, 14 days, and 84 days.

ArmMeasureValue (MEAN)Dispersion
FACT Was HelpfulCommunication Self-efficacy Measured by the Adapted Communication Self-Efficacy Scale78.8 score on a scaleStandard Deviation 20.6
14 DaysCommunication Self-efficacy Measured by the Adapted Communication Self-Efficacy Scale82.8 score on a scaleStandard Deviation 20.2
84 DaysCommunication Self-efficacy Measured by the Adapted Communication Self-Efficacy Scale82.8 score on a scaleStandard Deviation 23.5
p-value: 0.2t-test, 2 sided
Secondary

Feasibility of Recruitment

Number of patients who enroll in the study

Time frame: Baseline

Population: Number of individuals eligible for participation who enrolled in the study.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
FACT Was HelpfulFeasibility of RecruitmentNumber who consented for participation53 Participants
FACT Was HelpfulFeasibility of RecruitmentNumber who completed baseline assessments to receive intervention46 Participants
Secondary

Feasibility of Screening

The number of subjects who were screened, recruited, and retained in the study were reported.

Time frame: Baseline

Population: Number of individuals who were assessed for eligibility and found to eligible

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
FACT Was HelpfulFeasibility of ScreeningScreened69 Participants
FACT Was HelpfulFeasibility of ScreeningRecruited/consented53 Participants
FACT Was HelpfulFeasibility of ScreeningCompleted baseline intervention46 Participants
FACT Was HelpfulFeasibility of ScreeningCompleted 2-week intervention35 Participants
FACT Was HelpfulFeasibility of ScreeningCompleted 12-week intervention29 Participants

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026